Federal Register Notice: FDA is making available Draft Guidance for Industry, Bioequivalence: Blood Level Bioequivalence Study (VICH GL52) developed for veterinary use by the International Cooperation on Harmonization of Technical Requirements for Registration of Veterinary Medicinal Products (VICH). It is intended to harmonize the data recommendations associated with in vivo blood level bioequivalence (BE) for veterinary pharmaceutical products. To download this draft guidance, click here. To view this notice, click here.